Literature DB >> 29897280

Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension.

Ryan J Cornelius1, Chong Zhang2, Kayla J Erspamer1, Larry N Agbor3, Curt D Sigmund3, Jeffrey D Singer4, Chao-Ling Yang1, David H Ellison1,5.   

Abstract

Familial hyperkalemic hypertension is caused by mutations in with-no-lysine kinases (WNKs) or in proteins that mediate their degradation, kelch-like 3 (KLHL3) and cullin 3 (CUL3). Although the mechanisms by which WNK and KLHL3 mutations cause the disease are now clear, the effects of the disease-causing CUL3Δ403-459 mutation remain controversial. Possible mechanisms, including hyperneddylation, altered ubiquitin ligase activity, decreased association with the COP9 signalosome (CSN), and increased association with and degradation of KLHL3 have all been postulated. Here, we systematically evaluated the effects of Cul3Δ403-459 using cultured kidney cells. We first identified that the catalytically active CSN subunit jun activation domain-binding protein-1 (JAB1) does not associate with the deleted Cul3 4-helix bundle domain but instead with the adjacent α/β1 domain, suggesting that altered protein folding underlies the impaired binding. Inhibition of deneddylation with JAB1 siRNA increased Cul3 neddylation and decreased KLHL3 abundance, similar to the Cul3 mutant. We next determined that KLHL3 degradation has both ubiquitin ligase-dependent and -independent components. Proteasomal KLHL3 degradation was enhanced by Cul3Δ403-459; however, autophagic degradation was also upregulated by this Cul3 mutant. Finally, to evaluate whether deficient substrate adaptor was responsible for the disease, we restored KLHL3 to wild-type (WT) Cul3 levels. In the absence of WT Cul3, WNK4 was not degraded, demonstrating that Cul3Δ403-459 itself cannot degrade WNK4; conversely, when WT Cul3 was present, as in diseased humans, WNK4 degradation was restored. In conclusion, deletion of exon 9 from Cul3 generates a protein that is itself ubiquitin-ligase defective but also capable of enhanced autophagocytic KLHL3 degradation, thereby exerting dominant-negative effects on the WT allele.

Entities:  

Keywords:  JAB1; cullin-RING ubiquitin ligase; deneddylation; neddylation

Mesh:

Substances:

Year:  2018        PMID: 29897280      PMCID: PMC6230741          DOI: 10.1152/ajprenal.00602.2017

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  37 in total

1.  Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.

Authors:  James A McCormick; Chao-Ling Yang; Chong Zhang; Brittney Davidge; Katharina I Blankenstein; Andrew S Terker; Bethzaida Yarbrough; Nicholas P Meermeier; Hae J Park; Belinda McCully; Mark West; Aljona Borschewski; Nina Himmerkus; Markus Bleich; Sebastian Bachmann; Kerim Mutig; Eduardo R Argaiz; Gerardo Gamba; Jeffrey D Singer; David H Ellison
Journal:  J Clin Invest       Date:  2014-09-24       Impact factor: 14.808

2.  The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.

Authors:  Alberto C Vitari; Maria Deak; Nick A Morrice; Dario R Alessi
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

3.  Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.

Authors:  Haim Mayan; Iris Vered; Meir Mouallem; Michal Tzadok-Witkon; Rachel Pauzner; Zvi Farfel
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

4.  Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.

Authors:  Guojin Wu; Ji-Bin Peng
Journal:  FEBS Lett       Date:  2013-05-09       Impact factor: 4.124

5.  Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.

Authors:  Koichiro Susa; Eisei Sohara; Tatemitsu Rai; Moko Zeniya; Yutaro Mori; Takayasu Mori; Motoko Chiga; Naohiro Nomura; Hidenori Nishida; Daiei Takahashi; Kiyoshi Isobe; Yuichi Inoue; Kenta Takeishi; Naoki Takeda; Sei Sasaki; Shinichi Uchida
Journal:  Hum Mol Genet       Date:  2014-05-12       Impact factor: 6.150

Review 6.  Nedd8 on cullin: building an expressway to protein destruction.

Authors:  Zhen-Qiang Pan; Alex Kentsis; Dora C Dias; Kosj Yamoah; Kenneth Wu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

7.  WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.

Authors:  Emmanuelle Vidal-Petiot; Emilie Elvira-Matelot; Kerim Mutig; Christelle Soukaseum; Véronique Baudrie; Shengnan Wu; Lydie Cheval; Elizabeth Huc; Michèle Cambillau; Sebastian Bachmann; Alain Doucet; Xavier Jeunemaitre; Juliette Hadchouel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

8.  Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.

Authors:  Mohammed Z Ferdaus; Lauren N Miller; Larry N Agbor; Turgay Saritas; Jeffrey D Singer; Curt D Sigmund; James A McCormick
Journal:  JCI Insight       Date:  2017-12-21

Review 9.  The Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and Repair.

Authors:  Dudley Chung; Graham Dellaire
Journal:  Biomolecules       Date:  2015-09-30

10.  Generation and analysis of knock-in mice carrying pseudohypoaldosteronism type II-causing mutations in the cullin 3 gene.

Authors:  Yuya Araki; Tatemitsu Rai; Eisei Sohara; Takayasu Mori; Yuichi Inoue; Kiyoshi Isobe; Eriko Kikuchi; Akihito Ohta; Sei Sasaki; Shinichi Uchida
Journal:  Biol Open       Date:  2015-10-21       Impact factor: 2.422

View more
  11 in total

1.  Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.

Authors:  Larry N Agbor; Anand R Nair; Jing Wu; Ko-Ting Lu; Deborah R Davis; Henry L Keen; Frederick W Quelle; James A McCormick; Jeffrey D Singer; Curt D Sigmund
Journal:  JCI Insight       Date:  2019-06-11

Review 2.  Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding.

Authors:  Ryan J Cornelius; Chao-Ling Yang; David H Ellison
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-09

3.  COP9 signalosome deletion promotes renal injury and distal convoluted tubule remodeling.

Authors:  Ryan J Cornelius; Jonathan W Nelson; Xiao-Tong Su; Chao-Ling Yang; David H Ellison
Journal:  Am J Physiol Renal Physiol       Date:  2022-05-09

Review 4.  Cullin-3: Renal and Vascular Mechanisms Regulating Blood Pressure.

Authors:  Jing Wu; James A McCormick; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2020-08-27       Impact factor: 5.369

5.  Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.

Authors:  Ryan J Cornelius; Jinge Si; Catherina A Cuevas; Jonathan W Nelson; Brittany D K Gratreak; Ruggero Pardi; Chao-Ling Yang; David H Ellison
Journal:  J Am Soc Nephrol       Date:  2018-10-09       Impact factor: 10.121

Review 6.  Cullin-Ring ubiquitin ligases in kidney health and disease.

Authors:  Ryan J Cornelius; Mohammed Z Ferdaus; Jonathan W Nelson; James A McCormick
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-09       Impact factor: 2.894

7.  Novel CUL3 Variant Causing Familial Hyperkalemic Hypertension Impairs Regulation and Function of Ubiquitin Ligase Activity.

Authors:  Harish E Chatrathi; Jason C Collins; Lynne A Wolfe; Thomas C Markello; David R Adams; William A Gahl; Achim Werner; Prashant Sharma
Journal:  Hypertension       Date:  2021-12-02       Impact factor: 10.190

8.  Comorbidities Caused by a Corrupt Cullin 3: Lessons Learned From Bedside to Bench.

Authors:  Jing Wu; Curt D Sigmund
Journal:  Hypertension       Date:  2021-12-08       Impact factor: 10.190

9.  Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.

Authors:  Yujiro Maeoka; Mohammed Z Ferdaus; Ryan J Cornelius; Avika Sharma; Xiao-Tong Su; Lauren N Miller; Joshua A Robertson; Susan B Gurley; Chao-Ling Yang; David H Ellison; James A McCormick
Journal:  J Am Soc Nephrol       Date:  2022-01-21       Impact factor: 14.978

Review 10.  Role of the Peroxisome Proliferator Activated Receptors in Hypertension.

Authors:  Shi Fang; M Christine Livergood; Pablo Nakagawa; Jing Wu; Curt D Sigmund
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 23.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.